Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 30 Sept 2026, 20:22 UTC. 2 material updates are listed in the timeline. The headline in use is “Jade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis - Slideshow”. This note is SignalsMonitor's own briefing, not the publisher's article.